The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling.
about
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic modelA synthetic method for atmospheric diffusion simulation and environmental impact assessment of accidental pollution in the chemical industry in a WEBGIS context.Issues with the integration of technical information in planning for and responding to nontraditional disasters.Does Haber's law apply to human sensory irritation?Development and application of acute exposure guideline levels (AEGLs) for chemical warfare nerve and sulfur mustard agents.Acute respiratory symptoms and evacuation-related behavior after exposure to chlorine gas leakageApproaches for applications of physiologically based pharmacokinetic models in risk assessment.Modeling long-term effects attributed to nitrogen dioxide (NO2) and sulfur dioxide (SO2) exposure on asthma morbidity in a nationwide cohort in Israel.Technological challenges of addressing new and more complex migrating products from novel food packaging materials.Application of biological monitoring for exposure assessment following chemical incidents: a procedure for decision making.Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose.Organ growth functions in maturing male Sprague-Dawley rats based on a collective database.Organ growth functions in maturing male Sprague-Dawley rats.
P2860
Q24647832-F3EE7558-B4D6-4C7B-8A5B-EC74A60FCFC4Q34348157-806A63FF-8C2E-44D3-9FC7-FF3546CD1040Q36195210-67E387B1-E6E2-49D7-9B50-BE55B1DD3451Q36444199-448E0F22-7199-4C22-9CDB-F64B15C8003FQ36452389-AC3DF7FD-071B-4452-9F05-01808EBB68F2Q37064381-DC37208A-6AD1-4A7A-A01D-99FD6026B9CBQ37201545-30DFCEE3-4911-4BD2-914C-56478CB03C15Q38712012-F6BEA6F6-3432-48B8-8007-73BB64B8EB58Q39926132-781BB097-179A-4000-AD8A-A202F814D997Q41990053-8F2F8317-FCDF-4C20-BE27-02BBB8878896Q46601305-7C4F81CA-BD65-470E-A266-251825169650Q48170625-E588D92C-4116-4227-B900-975B5DDE8FD6Q48190885-B1EE8680-DEB6-4B0A-B6B0-B4568F2145EC
P2860
The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@ast
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@en
type
label
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@ast
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@en
prefLabel
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@ast
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@en
P2093
P2860
P1476
The Acute Exposure Guideline L ...... ased pharmacokinetic modeling.
@en
P2093
Deborah A Keys
James V Bruckner
Jeffrey W Fisher
P2860
P304
P356
10.1080/15287390490428017
P577
2004-04-01T00:00:00Z